Joel Greenblatt acquired 18.9 Thousand Veracyte shares worth $510 Thousand. That's 0.00% of their equity portfolio (1176th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares eight more times and sold shares on nine occasions. The stake costed the investor $442 Thousand, netting the investor a gain of 15% so far.